Published in Ann Vasc Surg on July 14, 2008
Endovascular management of a posttraumatic pseudoaneurysm of the common carotid artery with superselective coil embolization. J Vasc Surg (2010) 0.75
Cervical carotid pseudoaneurysm: A carotid artery stenting complication. Surg Neurol Int (2011) 0.75
Contemporary Strategies in the Management of Civilian Neck Zone II Vascular Trauma. Front Surg (2017) 0.75
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg (2002) 3.35
Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg (2007) 2.55
Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg (2002) 2.07
National outcomes for the treatment of ruptured abdominal aortic aneurysm: comparison of open versus endovascular repairs. J Vasc Surg (2008) 1.82
Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg (2011) 1.81
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2002) 1.75
Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg (2006) 1.72
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg (2009) 1.60
Reporting standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg (2010) 1.56
Defining high-risk patients for endovascular aneurysm repair. J Vasc Surg (2009) 1.56
Gender trends in the repair of ruptured abdominal aortic aneurysms and outcomes. J Vasc Surg (2010) 1.54
Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther (2011) 1.50
Gadodiamide administration causes spurious hypocalcemia. Radiology (2003) 1.47
Routine early postoperative duplex scanning is unnecessary following uncomplicated carotid endarterectomy. Vasc Endovascular Surg (2002) 1.42
Causes and implications of readmission after abdominal aortic aneurysm repair. Ann Surg (2012) 1.39
TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol (2009) 1.36
Simulation improves resident performance in catheter-based intervention: results of a randomized, controlled study. Ann Surg (2006) 1.35
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem (2009) 1.33
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg (2002) 1.29
Isolated iliac artery aneurysms: a contemporary comparison of endovascular and open repair. J Vasc Surg (2008) 1.27
Protein kinase C delta induces apoptosis of vascular smooth muscle cells through induction of the tumor suppressor p53 by both p38-dependent and p38-independent mechanisms. J Biol Chem (2005) 1.22
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc Res (2009) 1.20
Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg (2006) 1.20
PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2006) 1.16
Clinical practice. Abdominal aortic aneurysms. N Engl J Med (2014) 1.15
Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg (2009) 1.15
Insurance status predicts access to care and outcomes of vascular disease. J Vasc Surg (2008) 1.15
Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg (2010) 1.14
The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg (2007) 1.13
Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation (2002) 1.12
Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg (2004) 1.12
Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg (2007) 1.12
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res (2004) 1.11
TGF-β and restenosis revisited: a Smad link. J Surg Res (2011) 1.10
Computer simulation as a component of catheter-based training. J Vasc Surg (2004) 1.09
An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. J Vasc Surg (2010) 1.09
Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg (2004) 1.08
PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem (2005) 1.07
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol (2005) 1.07
Contrast material travel times in patients undergoing peripheral MR angiography. Radiology (2002) 1.06
Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg (2003) 1.06
The cost-effectiveness of a "quick-screen" program for abdominal aortic aneurysms. Surgery (2002) 1.06
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg (2008) 1.05
Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients. Stroke (2013) 1.05
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg (2004) 1.04
Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2009) 1.02
Intimal hyperplasia--still here after all these years! Ann Vasc Surg (2004) 1.01
Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. J Vasc Surg (2007) 1.01
Incidence of moderate to severe cognitive dysfunction in patients treated with carotid artery stenting. Neurosurgery (2009) 1.00
Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model. Arterioscler Thromb Vasc Biol (2012) 1.00
Type I collagen synergistically enhances PDGF-induced smooth muscle cell proliferation through pp60src-dependent crosstalk between the alpha2beta1 integrin and PDGFbeta receptor. Biochem Biophys Res Commun (2004) 1.00
Multimodal therapy for acute and chronic venous thrombotic and occlusive disease. Vasc Endovascular Surg (2005) 0.99
Angiographic access site complications in the era of arterial closure devices. Vasc Endovascular Surg (2002) 0.99
The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg (2008) 0.98
Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg (2011) 0.98
The creation of an infrarenal aneurysm within the native abdominal aorta of swine. Surgery (2007) 0.97
Abdominal aortic aneurysm in women: prevalence, risk factors, and implications for screening. J Vasc Surg (2007) 0.96
Upregulation of protein kinase cdelta in vascular smooth muscle cells promotes inflammation in abdominal aortic aneurysm. J Surg Res (2008) 0.96
Is carotid angioplasty and stenting more cost effective than carotid endarterectomy? J Vasc Surg (2003) 0.95
Carotid angioplasty and stent-induced bradycardia and hypotension: Impact of prophylactic atropine administration and prior carotid endarterectomy. J Vasc Surg (2005) 0.95
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. J Vasc Surg (2012) 0.95
Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagents. Biomaterials (2008) 0.94
The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation. Surgery (2002) 0.94
Endovascular aneurysm repair--is it durable? N Engl J Med (2010) 0.94
Current management of extracranial carotid artery disease. Vasc Endovascular Surg (2006) 0.93
Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-β/Smad3-treated medial smooth muscle cells. Cell Signal (2012) 0.93
Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg (2005) 0.93
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2003) 0.92
Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin. Am J Physiol Heart Circ Physiol (2005) 0.92
TGF-beta stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. J Surg Res (2003) 0.92
Local drug delivery to prevent restenosis. J Vasc Surg (2013) 0.92
National trends in the repair of ruptured abdominal aortic aneurysms. J Vasc Surg (2008) 0.92
Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurements. J Magn Reson Imaging (2006) 0.91
TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2012) 0.91
The novel function of advanced glycation end products in regulation of MMP-9 production. J Surg Res (2010) 0.91
Phosphorylation of the cyclic AMP response element binding protein mediates transforming growth factor beta-induced downregulation of cyclin A in vascular smooth muscle cells. Mol Cell Biol (2007) 0.90
Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg (2006) 0.90
Minimally invasive retrieval of a dislodged Wallstent endoprosthesis after an endovascular abdominal aortic aneurysm repair. J Vasc Surg (2008) 0.90
Redo infrainguinal bypass: factors predicting patency and limb salvage. Ann Vasc Surg (2003) 0.90
Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg (2008) 0.89
Outcomes of carotid stenting compared with endarterectomy are equivalent in asymptomatic patients and inferior in symptomatic patients. J Vasc Surg (2010) 0.89
Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. J Vasc Surg (2005) 0.89
Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb ischemia. Am Surg (2005) 0.88
Reporting standards for carotid interventions from the Society for Vascular Surgery. J Vasc Surg (2011) 0.88
Is there a relationship between patient satisfaction and favorable outcomes? Ann Surg (2014) 0.88
Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions. J Vasc Surg (2010) 0.88